Compendium of Cancer Genome Aberrations

BRST5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 105: Line 105:
|
|
|-
|-
|[[BRST5:Tubular adenoma|Tubular adenoma]||Disease||
|[[BRST5:Tubular adenoma|Tubular adenoma]]||Disease||
|
|
|
|
Line 197: Line 197:
|
|
|-
|-
|[[BRST5:Solid papillary carcinoma (in situ and invasive)|Solid papillary carcinoma (in situ and invasive)[[||Disease||
|[[BRST5:Solid papillary carcinoma (in situ and invasive)|Solid papillary carcinoma (in situ and invasive)]]||Disease||
|
|
|
|
Line 336: Line 336:
!'''Notes'''
!'''Notes'''
|-
|-
|Carcinoma with apocrine differentiation||Disease||
|[[BRST5:Carcinoma with apocrine differentiation|Carcinoma with apocrine differentiation]]||Disease||
|
|
|
|
Line 345: Line 345:
|
|
|-
|-
|Metaplastic carcinoma||Disease||
|[[BRST5:Metaplastic carcinoma|Metaplastic carcinoma]]||Disease||
|
|
|
|
Line 381: Line 381:
|2024 template added
|2024 template added
|-
|-
|Mucoepidermoid carcinoma||Disease||
|[[BRST5:Mucoepidermoid carcinoma|Mucoepidermoid carcinoma]]||Disease||
|
|
|
|
Line 390: Line 390:
|
|
|-
|-
|Polymorphous adenocarcinoma||Disease||
|[[BRST5:Polymorphous adenocarcinoma|Polymorphous adenocarcinoma]]||Disease||
|
|
|
|
Line 408: Line 408:
|2024 template added
|2024 template added
|-
|-
|Neuroendocrine tumour||Disease||
|[[BRST5:Neuroendocrine tumour|Neuroendocrine tumour]]||Disease||
|
|
|
|
Line 417: Line 417:
|
|
|-
|-
|Neuroendocrine carcinoma||Disease||
|[[BRST5:Neuroendocrine carcinoma|Neuroendocrine carcinoma]]||Disease||
|
|
|
|
Line 458: Line 458:
----
----
|-
|-
|Hamartoma||Disease||
|[[BRST5:Hamartoma|Hamartoma]]||Disease||
|
|
|
|
Line 506: Line 506:
----
----
|-
|-
|Syringomatous tumour||Disease||
|[[BRST5:Syringomatous tumour|Syringomatous tumour]]||Disease||
|
|
|
|
Line 515: Line 515:
|
|
|-
|-
|Nipple adenoma||Disease||
|[[BRST5:Nipple adenoma|Nipple adenoma]]||Disease||
|
|
|
|
Line 524: Line 524:
|
|
|-
|-
|Paget disease of the breast||Disease||
|[[BRST5:Paget disease of the breast|Paget disease of the breast]]||Disease||
|
|
|
|
Line 554: Line 554:
----
----
|-
|-
|Haemangioma||Disease||
|[[BRST5:Haemangioma|Haemangioma]]||Disease||
|
|
|
|
Line 574: Line 574:
!'''Notes'''
!'''Notes'''
|-
|-
|Angiomatosis||Disease||
|[[BRST5:Angiomatosis|Angiomatosis]]||Disease||
|
|
|
|
Line 583: Line 583:
|
|
|-
|-
|Atypical vascular lesions||Disease||
|[[BRST5:Atypical vascular lesions|Atypical vascular lesions]]||Disease||
|
|
|
|
Line 592: Line 592:
|
|
|-
|-
|Postradiation angiosarcoma of the breast||Disease||
|[[BRST5:Postradiation angiosarcoma of the breast|Postradiation angiosarcoma of the breast]]||Disease||
|
|
|
|
Line 601: Line 601:
|
|
|-
|-
|Primary angiosarcoma of the breast||Disease||
|[[BRST5:Primary angiosarcoma of the breast|Primary angiosarcoma of the breast]]||Disease||
|
|
|
|
Line 610: Line 610:
|
|
|-
|-
|Nodular fasciitis||Disease||
|[[BRST5:Nodular fasciitis|Nodular fasciitis]]||Disease||
|
|
|
|
Line 619: Line 619:
|
|
|-
|-
|Myofibroblastoma||Disease||
|[[BRST5:Myofibroblastoma|Myofibroblastoma]]||Disease||
|
|
|
|
Line 628: Line 628:
|
|
|-
|-
|Desmoid fibromatosis||Disease||
|[[BRST5:Desmoid fibromatosis|Desmoid fibromatosis]]||Disease||
|
|
|
|
Line 646: Line 646:
|2024 template
|2024 template
|-
|-
|Schwannoma||Disease||
|[[BRST5:Schwannoma|Schwannoma]]||Disease||
|
|
|
|
Line 655: Line 655:
|
|
|-
|-
|Neurofibroma||Disease||
|[[BRST5:Neurofibroma|Neurofibroma]]||Disease||
|
|
|
|
Line 675: Line 675:
!'''Notes'''
!'''Notes'''
|-
|-
|Granular cell tumour||Disease||
|[[BRST5:Granular cell tumour|Granular cell tumour]]||Disease||
|
|
|
|
Line 684: Line 684:
|
|
|-
|-
|Leiomyoma||Disease||
|[[BRST5:Leiomyoma|Leiomyoma]]||Disease||
|
|
|
|
Line 693: Line 693:
|
|
|-
|-
|Leiomyosarcoma||Disease||
|[[BRST5:Leiomyosarcoma|Leiomyosarcoma]]||Disease||
|
|
|
|
Line 702: Line 702:
|
|
|-
|-
|Lipoma||Disease||
|[[BRST5:Lipoma|Lipoma]]||Disease||
|
|
|
|
Line 711: Line 711:
|
|
|-
|-
|Angiolipoma||Disease||
|[[BRST5:Angiolipoma|Angiolipoma]]||Disease||
|
|
|
|
Line 720: Line 720:
|
|
|-
|-
|Liposarcoma||Disease||
|[[BRST5:Liposarcoma|Liposarcoma]]||Disease||
|
|
|
|
Line 729: Line 729:
|
|
|-
|-
|Pseudoangiomatous stromal hyperplasia||Disease||
|[[BRST5:Pseudoangiomatous stromal hyperplasia|Pseudoangiomatous stromal hyperplasia]]||Disease||
|
|
|
|
Line 759: Line 759:
----
----
|-
|-
|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease||
|[[BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]||Disease||
|
|
|
|
Line 768: Line 768:
|
|
|-
|-
|Follicular lymphoma||Disease||
|[[BRST5:Follicular lymphoma|Follicular lymphoma]]||Disease||
|
|
|
|
Line 788: Line 788:
!'''Notes'''
!'''Notes'''
|-
|-
|Diffuse large B-cell lymphoma||Disease||
|[[BRST5:Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma]]||Disease||
|
|
|
|
Line 797: Line 797:
|
|
|-
|-
|Burkitt lymphoma||Disease||
|[[BRST5:Burkitt lymphoma|Burkitt lymphoma]]||Disease||
|
|
|
|
Line 806: Line 806:
|
|
|-
|-
|Breast implant-associated anaplastic large cell lymphoma||Disease||
|[[BRST5:Breast implant-associated anaplastic large cell lymphoma|Breast implant-associated anaplastic large cell lymphoma]]||Disease||
|
|
|
|
Line 836: Line 836:
----
----
|-
|-
|Gynaecomastia||Disease||
|[[BRST5:Gynaecomastia|Gynaecomastia]]||Disease||
|
|
|
|
Line 845: Line 845:
|
|
|-
|-
|Carcinoma in situ||Disease||
|[[BRST5:Carcinoma in situ|Carcinoma in situ]]||Disease||
|
|
|
|
Line 854: Line 854:
|
|
|-
|-
|Invasive carcinoma||Disease||
|[[BRST5:Invasive carcinoma|Invasive carcinoma]||Disease||
|
|
|
|
Line 863: Line 863:
|
|
|-
|-
|Metastases to the breast||Disease||
|[[BRST5:Metastases to the breast|Metastases to the breast]||Disease||
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/BRST5:Volunteer_Assignments_and_Opportunities"